ACUTE rheumatic fever, in the absence of intercurrent streptococcal respiratory infections and rheumatic recrudescences, is generally a self-limited disease that subsides within twelve weeks.

Rheumatic heart disease is a chronic condition that results years after acute rheumatic fever, which is caused by group A beta-hemolytic Streptococcus pyogenes. This organism produces a ...

The historical record shows that the battle to prevent and find cures for infectious disease will lead to a lower incidence ...

But in the first part of the 20th century, it was ever-present, untreatable and devastating. "About 100 years ago, there were more pediatric hospital beds occupied by children with rheumatic fever ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

Health's content is for informational and educational purposes only. Our website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Health is part of the ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

Higher rates of childhood Streptococcus pyogenes (group A Streptococcus (GAS)) infections following the COVID-19 pandemic have exposed uncertainty about the epidemiology of immune-mediated ...

A RECENT review of the literature 1 and our own experience at the House of the Good Samaritan 2–5 suggest that early treatment of rheumatic fever with ACTH and cortisone may prevent or mitigate ...

The research of the Helsinki Rheumatic diseases and Inflammation Group focuses on studying the mechanisms of inflammation in rheumatic diseases and osteoarthritis, with special emphasis on role of ...

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.